Zealand Pharma A/S
CSE:ZEAL

Watchlist Manager

Zealand Pharma A/S

CSE:ZEAL

Watchlist

Dividends

Price: 726.5 DKK 4.23% Market Closed

Market Cap: 51.5B DKK

Have any thoughts about
Zealand Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 726.5 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ZEAL Alert

Zealand Pharma A/S

726.5

+29.5 (+4.23%)

52 Week Range	315.4 954
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Zealand Pharma A/S

What unique competitive advantages
does Zealand Pharma A/S hold over its rivals?

What risks and challenges
does Zealand Pharma A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Zealand Pharma A/S.

What unique competitive advantages
does Zealand Pharma A/S hold over its rivals?

What risks and challenges
does Zealand Pharma A/S face in the near future?

Summarize the latest earnings call
of Zealand Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Zealand Pharma A/S.

Provide P/S
for Zealand Pharma A/S.

Provide P/E
for Zealand Pharma A/S.

Provide P/OCF
for Zealand Pharma A/S.

Provide P/FCFE
for Zealand Pharma A/S.

Provide P/B
for Zealand Pharma A/S.

Provide EV/S
for Zealand Pharma A/S.

Provide EV/GP
for Zealand Pharma A/S.

Provide EV/EBITDA
for Zealand Pharma A/S.

Provide EV/EBIT
for Zealand Pharma A/S.

Provide EV/OCF
for Zealand Pharma A/S.

Provide EV/FCFF
for Zealand Pharma A/S.

Provide EV/IC
for Zealand Pharma A/S.

Show me price targets
for Zealand Pharma A/S made by professional analysts.

What are the Revenue projections
for Zealand Pharma A/S?

How accurate were the past Revenue estimates
for Zealand Pharma A/S?

What are the Net Income projections
for Zealand Pharma A/S?

How accurate were the past Net Income estimates
for Zealand Pharma A/S?

What are the EPS projections
for Zealand Pharma A/S?

How accurate were the past EPS estimates
for Zealand Pharma A/S?

What are the EBIT projections
for Zealand Pharma A/S?

How accurate were the past EBIT estimates
for Zealand Pharma A/S?

Compare the revenue forecasts
for Zealand Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Zealand Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Zealand Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Zealand Pharma A/S compared to its peers.

Compare the P/E ratios
of Zealand Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Zealand Pharma A/S with its peers.

Analyze the financial leverage
of Zealand Pharma A/S compared to its main competitors.

Show all profitability ratios
for Zealand Pharma A/S.

Provide ROE
for Zealand Pharma A/S.

Provide ROA
for Zealand Pharma A/S.

Provide ROIC
for Zealand Pharma A/S.

Provide ROCE
for Zealand Pharma A/S.

Provide Gross Margin
for Zealand Pharma A/S.

Provide Operating Margin
for Zealand Pharma A/S.

Provide Net Margin
for Zealand Pharma A/S.

Provide FCF Margin
for Zealand Pharma A/S.

Show all solvency ratios
for Zealand Pharma A/S.

Provide D/E Ratio
for Zealand Pharma A/S.

Provide D/A Ratio
for Zealand Pharma A/S.

Provide Interest Coverage Ratio
for Zealand Pharma A/S.

Provide Altman Z-Score Ratio
for Zealand Pharma A/S.

Provide Quick Ratio
for Zealand Pharma A/S.

Provide Current Ratio
for Zealand Pharma A/S.

Provide Cash Ratio
for Zealand Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Zealand Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Zealand Pharma A/S?

What is the current Free Cash Flow
of Zealand Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Zealand Pharma A/S.

P/OCF
Price to OCF

-74.3

Current

-14.2

Median

21.6

Industry

Lower than median

Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF

-74.3

Market Cap

51.3B DKK

Operating Cash Flow

-690.8m DKK

All Countries

Forward Multiples

			Market Cap	P/OCF
DK		Zealand Pharma A/S CSE:ZEAL	51.3B DKK	-74.3
FR		Pharnext SCA OTC:PNEXF	6T USD	-239 316.7
US		Abbvie Inc NYSE:ABBV	312.7B USD	18.9
US		Amgen Inc NASDAQ:AMGN	158.3B USD	21.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	-137.9
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	11.2
US	E	Epizyme Inc F:EPE	94.1B EUR	-470.1
AU		CSL Ltd ASX:CSL	133.6B AUD	31.4
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	19.1
US	S	Seagen Inc F:SGT	39.3B EUR	-75.9
NL		argenx SE XBRU:ARGX	34.8B EUR	-139.8


DK		Zealand Pharma A/S CSE:ZEAL	Average P/OCF: 20.5 Negative Multiple: -74.3
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -239 316.7
US		Abbvie Inc NYSE:ABBV	18.9
US		Amgen Inc NASDAQ:AMGN	21.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	Negative Multiple: -137.9
US		Gilead Sciences Inc NASDAQ:GILD	11.2
US	E	Epizyme Inc F:EPE	Negative Multiple: -470.1
AU		CSL Ltd ASX:CSL	31.4
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	19.1
US	S	Seagen Inc F:SGT	Negative Multiple: -75.9
NL		argenx SE XBRU:ARGX	Negative Multiple: -139.8

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/OCF

N/A

2-Years Forward

P/OCF

N/A

3-Years Forward

P/OCF

N/A

Zealand Pharma A/S
CSE:ZEAL

P/OCF
Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Zealand Pharma A/S CSE:ZEAL

P/OCF Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

Zealand Pharma A/S
CSE:ZEAL

P/OCF
Price to OCF